Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Apohem1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Apohem1flox/Cya

Common Name
Apoh-flox
Product ID
S-CKO-19497
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-11818-Apoh-B6J-VB
Status
Research and Development
When using this mouse strain in a publication, please cite “Apoh-flox Mouse (Catalog S-CKO-19497) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Apoh-flox
Strain ID
CKOCMP-11818-Apoh-B6J-VB
Gene Name
Apoh
Product ID
S-CKO-19497
Gene Alias
B2GPI, beta2-GPI, beta-2-GPI
Background
C57BL/6JCya
Gene Full Name
apolipoprotein H
Modification
Conditional knockout
NCBI ID
11818 (Mouse)
Phenotype
MGI:88058
Chromosome
Chr 11 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000000049
NCBI Transcript ID
NM_013475
Target Region
Exon 3
Size of Effective Region
~0.9 kb
Overview of Gene Research
Apoh, also known as apolipoprotein H, is involved in lipid metabolism, regulating triglycerides, and has a role in pathways related to complement and coagulation regulation [3,6,7]. It is one of the apolipoproteins that can bind free fatty acids, regulate the activity of many proteins involved in HDL metabolism, inhibit lipid transfer, and control the endogenous coagulation cascade [5].

In antiphospholipid syndrome (APS), both exosomes containing APOH (APOH-exos) and APS-exos impair vascular development and lead to pregnancy complications. APOH-exos may be key in the pathogenesis of APS as they can directly enter human umbilical vein endothelial cells (HUVECs) and may act through the phospho-extracellular signal-regulated kinase pathway [1]. Also, in APS patients, polymorphisms in the APOH gene (rs1801690, rs52797880, and rs8178847) are associated with susceptibility to recurrent pregnancy loss (RPL) [2].

In type 2 diabetic patients, APOH plasma levels are associated with metabolic syndrome (MS) alterations and vascular disease, with enhanced levels due to increased liver synthesis [3]. In diabetic kidney disease, the mRNA expression level of Apoh was declined [4]. In Influenza infection, low plasma levels of ApoH are associated with a worse prognosis and respiratory failure [7].

In conclusion, Apoh is crucial in lipid metabolism, complement and coagulation regulation. Its study through various models has revealed its significant roles in diseases such as APS, type 2 diabetes, diabetic kidney disease, and influenza infection. Understanding Apoh's functions can potentially provide new therapeutic targets for these diseases.

References:
1. Tan, Yuan, Bian, Yiding, Song, Yunfeng, Zhang, Qinhua, Wan, Xiaoping. 2021. Exosome-Contained APOH Associated With Antiphospholipid Syndrome. In Frontiers in immunology, 12, 604222. doi:10.3389/fimmu.2021.604222. https://pubmed.ncbi.nlm.nih.gov/34040601/
2. Deng, Xujing, Sang, Qing, Zhang, Ruixiu, Mu, Jian, Bao, Shihua. 2023. The association of APOH and NCF1 polymorphisms on susceptibility to recurrent pregnancy loss in women with antiphospholipid syndrome. In Journal of assisted reproduction and genetics, 40, 1703-1712. doi:10.1007/s10815-023-02829-5. https://pubmed.ncbi.nlm.nih.gov/37243946/
3. Castro, Antoni, Lázaro, Iolanda, Selva, David M, Simó, Rafael, Masana, Lluís. 2009. APOH is increased in the plasma and liver of type 2 diabetic patients with metabolic syndrome. In Atherosclerosis, 209, 201-5. doi:10.1016/j.atherosclerosis.2009.09.072. https://pubmed.ncbi.nlm.nih.gov/19878946/
4. Zhao, Jing, He, Kaiying, Du, Hongxuan, Zhou, Xiaochun, Wang, Jianqin. 2022. Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice. In PeerJ, 10, e13932. doi:10.7717/peerj.13932. https://pubmed.ncbi.nlm.nih.gov/36157062/
5. Deng, Siying, Xu, Yangkai, Zheng, Lemin. . HDL Structure. In Advances in experimental medicine and biology, 1377, 1-11. doi:10.1007/978-981-19-1592-5_1. https://pubmed.ncbi.nlm.nih.gov/35575917/
6. Gu, W, Ray, K, Pearce-Kelling, S, Acland, G M, Aguirre, G D. . Evaluation of the APOH gene as a positional candidate for prcd in dogs. In Investigative ophthalmology & visual science, 40, 1229-37. doi:. https://pubmed.ncbi.nlm.nih.gov/10235557/
7. Garcinuño, Sara, Lalueza, Antonio, Gil-Etayo, Francisco Javier, Serrano, Antonio, Serrano, Manuel. 2024. Immune dysregulation is an important factor in the underlying complications in Influenza infection. ApoH, IL-8 and IL-15 as markers of prognosis. In Frontiers in immunology, 15, 1443096. doi:10.3389/fimmu.2024.1443096. https://pubmed.ncbi.nlm.nih.gov/39176097/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research